BIOYF Dividend: BioSyent Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

BIOYF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	42	35	31	27	28	22
Revenue Growth (YoY)	24%	13%	15%	-4%	27%	5%
Cost of Revenue	9	7	5	5	5	4
Gross Profit	32	27	25	22	22	17
Selling, General & Admin	20	18	17	15	13	11
Research & Development	0	0	0	0	0	0
Operating Expenses	21	18	18	15	14	12
Other Non Operating Income (Expenses)	--	--	--	0	0	--
Pretax Income	11	9	8	7	8	5
Income Tax Expense	3	2	2	1	2	1
Net Income	8	7	6	5	6	3
Net Income Growth	14%	17%	20%	-17%	100%	-25%
Shares Outstanding (Diluted)	11.5	11.8	12.17	12.54	12.87	13.09
Shares Change (YoY)	-3%	-3%	-3%	-3%	-2%	-6%
EPS (Diluted)	0.74	0.61	0.53	0.43	0.48	0.28
EPS Growth	25%	16%	22%	-11%	68%	-7%
Free Cash Flow	8	8	4	4	4	6
Free Cash Flow Per Share	0.69	0.67	0.32	0.31	0.31	0.45
Gross Margin	76.19%	77.14%	80.64%	81.48%	78.57%	77.27%
Operating Margin	23.8%	25.71%	22.58%	25.92%	28.57%	22.72%
Profit Margin	19.04%	20%	19.35%	18.51%	21.42%	13.63%
Free Cash Flow Margin	19.04%	22.85%	12.9%	14.81%	14.28%	27.27%
EBITDA	10	9	7	7	8	5
EBITDA Margin	23.8%	25.71%	22.58%	25.92%	28.57%	22.72%
D&A For EBITDA	0	0	0	0	0	0
EBIT	10	9	7	7	8	5
EBIT Margin	23.8%	25.71%	22.58%	25.92%	28.57%	22.72%
Effective Tax Rate	27.27%	22.22%	25%	14.28%	25%	20%